Literature DB >> 16199867

Nucleophosmin is required for DNA integrity and p19Arf protein stability.

Emanuela Colombo1, Paola Bonetti, Eros Lazzerini Denchi, Paola Martinelli, Raffaella Zamponi, Jean-Christophe Marine, Kristian Helin, Brunangelo Falini, Pier Giuseppe Pelicci.   

Abstract

Nucleophosmin (NPM) is a nucleolar phosphoprotein that binds the tumor suppressors p53 and p19(Arf) and is thought to be indispensable for ribogenesis, cell proliferation, and survival after DNA damage. The NPM gene is the most frequent target of genetic alterations in leukemias and lymphomas, though its role in tumorigenesis is unknown. We report here the first characterization of a mouse NPM knockout strain. Lack of NPM expression results in accumulation of DNA damage, activation of p53, widespread apoptosis, and mid-stage embryonic lethality. Fibroblasts explanted from null embryos fail to grow and rapidly acquire a senescent phenotype. Transfer of the NPM mutation into a p53-null background rescued apoptosis in vivo and fibroblast proliferation in vitro. Cells null for both p53 and NPM grow faster than control cells and are more susceptible to transformation by activated oncogenes, such as mutated Ras or overexpressed Myc. In the absence of NPM, Arf protein is excluded from nucleoli and is markedly less stable. Our data demonstrate that NPM regulates DNA integrity and, through Arf, inhibits cell proliferation and are consistent with a putative tumor-suppressive function of NPM.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16199867      PMCID: PMC1265791          DOI: 10.1128/MCB.25.20.8874-8886.2005

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  43 in total

Review 1.  Live or let die: the cell's response to p53.

Authors:  Karen H Vousden; Xin Lu
Journal:  Nat Rev Cancer       Date:  2002-08       Impact factor: 60.716

2.  Short exposure to actinomycin D induces "reversible" translocation of protein B23 as well as "reversible" inhibition of cell growth and RNA synthesis in HeLa cells.

Authors:  B Y Yung; A M Bor; P K Chan
Journal:  Cancer Res       Date:  1990-09-15       Impact factor: 12.701

3.  A B-cell-specific DNA recombination complex.

Authors:  T Borggrefe; M Wabl; A T Akhmedov; R Jessberger
Journal:  J Biol Chem       Date:  1998-07-03       Impact factor: 5.157

4.  Cytokine rescue of p53-dependent apoptosis and cell cycle arrest is mediated by distinct Jak kinase signaling pathways.

Authors:  F W Quelle; J Wang; J Feng; D Wang; J L Cleveland; J N Ihle; G P Zambetti
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

5.  Disruption and sequence identification of 2,000 genes in mouse embryonic stem cells.

Authors:  B P Zambrowicz; G A Friedrich; E C Buxton; S L Lilleberg; C Person; A T Sands
Journal:  Nature       Date:  1998-04-09       Impact factor: 49.962

6.  Characterization of the cDNA encoding human nucleophosmin and studies of its role in normal and abnormal growth.

Authors:  W Y Chan; Q R Liu; J Borjigin; H Busch; O M Rennert; L A Tease; P K Chan
Journal:  Biochemistry       Date:  1989-02-07       Impact factor: 3.162

7.  Down-regulation of nucleophosmin/B23 during retinoic acid-induced differentiation of human promyelocytic leukemia HL-60 cells.

Authors:  C Y Hsu; B Y Yung
Journal:  Oncogene       Date:  1998-02-19       Impact factor: 9.867

8.  Expression of nucleophosmin/B23 in normal and neoplastic colorectal mucosa.

Authors:  Y Nozawa; N Van Belzen; A C Van der Made; W N Dinjens; F T Bosman
Journal:  J Pathol       Date:  1996-01       Impact factor: 7.996

9.  Tumor spectrum analysis in p53-mutant mice.

Authors:  T Jacks; L Remington; B O Williams; E M Schmitt; S Halachmi; R T Bronson; R A Weinberg
Journal:  Curr Biol       Date:  1994-01-01       Impact factor: 10.834

10.  Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma.

Authors:  S W Morris; M N Kirstein; M B Valentine; K G Dittmer; D N Shapiro; D L Saltman; A T Look
Journal:  Science       Date:  1994-03-04       Impact factor: 47.728

View more
  88 in total

1.  RNA helicase DDX5 is a p53-independent target of ARF that participates in ribosome biogenesis.

Authors:  Anthony J Saporita; Hsiang-Chun Chang; Crystal L Winkeler; Anthony J Apicelli; Raleigh D Kladney; Jianbo Wang; R Reid Townsend; Loren S Michel; Jason D Weber
Journal:  Cancer Res       Date:  2011-09-21       Impact factor: 12.701

2.  Human AP-endonuclease (Ape1) activity on telomeric G4 structures is modulated by acetylatable lysine residues in the N-terminal sequence.

Authors:  Silvia Burra; Daniela Marasco; Matilde Clarissa Malfatti; Giulia Antoniali; Antonella Virgilio; Veronica Esposito; Bruce Demple; Aldo Galeone; Gianluca Tell
Journal:  DNA Repair (Amst)       Date:  2018-11-22

3.  Epigenomic differentiation in mouse preimplantation nuclei of biparental, parthenote and cloned embryos.

Authors:  Valeria Merico; Jessica Barbieri; Maurizio Zuccotti; Boris Joffe; Thomas Cremer; Carlo Alberto Redi; Irina Solovei; Silvia Garagna
Journal:  Chromosome Res       Date:  2007-05-10       Impact factor: 5.239

4.  Development of a malignancy-associated proteomic signature for diffuse large B-cell lymphoma.

Authors:  Paul B Romesser; David H Perlman; Douglas V Faller; Catherine E Costello; Mark E McComb; Gerald V Denis
Journal:  Am J Pathol       Date:  2009-06-04       Impact factor: 4.307

Review 5.  Insights into the regulation of neuronal viability by nucleophosmin/B23.

Authors:  Jason A Pfister; Santosh R D'Mello
Journal:  Exp Biol Med (Maywood)       Date:  2015-04-22

6.  Nucleophosmin suppresses oncogene-induced apoptosis and senescence and enhances oncogenic cooperation in cells with genomic instability.

Authors:  June Li; Daniel P Sejas; Sandeep Burma; David J Chen; Qishen Pang
Journal:  Carcinogenesis       Date:  2007-02-02       Impact factor: 4.944

Review 7.  Nucleophosmin (NPM1) mutations in adult and childhood acute myeloid leukaemia: towards definition of a new leukaemia entity.

Authors:  Rachel Rau; Patrick Brown
Journal:  Hematol Oncol       Date:  2009-12       Impact factor: 5.271

8.  Selective inhibitors of nuclear export show that CRM1/XPO1 is a target in chronic lymphocytic leukemia.

Authors:  Rosa Lapalombella; Qingxiang Sun; Katie Williams; Larissa Tangeman; Shruti Jha; Yiming Zhong; Virginia Goettl; Emilia Mahoney; Caroline Berglund; Sneha Gupta; Alicia Farmer; Rajeswaran Mani; Amy J Johnson; David Lucas; Xiaokui Mo; Dirk Daelemans; Vincent Sandanayaka; Sharon Shechter; Dilara McCauley; Sharon Shacham; Michael Kauffman; Yuh Min Chook; John C Byrd
Journal:  Blood       Date:  2012-10-03       Impact factor: 22.113

9.  Nucleophosmin contributes to the transcriptional activation function of the Epstein-Barr virus EBNA1 protein.

Authors:  Natasha Malik-Soni; Lori Frappier
Journal:  J Virol       Date:  2013-11-27       Impact factor: 5.103

10.  Nucleophosmin, a critical Bax cofactor in ischemia-induced cell death.

Authors:  Zhiyong Wang; Jonathan M Gall; Ramon Bonegio; Andrea Havasi; Katarina Illanes; John H Schwartz; Steven C Borkan
Journal:  Mol Cell Biol       Date:  2013-03-04       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.